InvestorsHub Logo
Followers 65
Posts 23858
Boards Moderated 0
Alias Born 11/23/2016

Re: WolfofMia post# 452436

Thursday, 02/22/2024 10:19:27 AM

Thursday, February 22, 2024 10:19:27 AM

Post# of 461408
I have posted many times, too many some believe, that further likely precision medicine P3 trials will be required. I stand by this likelihood and look forward to see which and how biomarkers correlate to benefit and dose versus placebo. This despite the '85% chance' of EMA approval of AD with A2-73 from the P2b/3 trial data.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News